Mumbai cruise drugs case: NCB summons witness Prabhakar Sail in connection with his allegations of pay off

10:31 PM Oct 26, 2021 | FPJ Web Desk

Narcotics Bureau of Mumbai has issued summons to witness Prabhakar Sail tomorrow for questioning in connection with his allegations of corruption in ongoing Mumbai cruise drugs case. A five-member team of the NCB is likely to visit Mumbai tomorrow to probe allegations by Prabhakar Sail in the matter.

According to ANI, the team will comprise Deputy Director General (DDG) NCB Gyaneshwar Singh and 4 other NCB officers.


"A five-member team of NCB will go from Delhi to Mumbai tomorrow to probe the allegations of corruption made by Prabhakar Sail, who is a witness in the drugs-on-cruise matter of Mumbai. The team will comprise DDG NCB Gyaneshwar Singh along with 4 other NCB officers," sources told ANI.


The bodyguard of NCB witness Kiran Gosavi, Prabhakar Rohoji Sail alleged that Gosavi took Rs 50 lakh from an individual after the raid at the cruise ship. Sali had said, "I worked as a bodyguard of Kiran Gosavi. I assisted him during the Mumbai cruise drugs case." However, the NCB named Sail as a "hostile witness" in its affidavit in court yesterday.

However, NCB zonal director Sameer Wankhede has already denied the allegation.

On October 18, a case was registered against Gosavi, the man who was seen accosting Bollywood actor Shah Rukh Khan's son Aryan Khan at Narcotics Control Bureau's (NCB) office in connection with the drugs-on-cruise matter.

An NCB team busted an alleged drugs party on the Cordelia Cruise ship which was on its way to Goa at mid-sea on October 2.

A total of 20 people, including Bollywood actor Shahrukh Khan's son Aryan Khan, have been arrested so far in the case.

(With agency inputs)

Also Read: Aryan Khan drug case: NCB's Sameer Wankhede visits Delhi headquarters amidst uproar over extortion charges against him - See pics

(To view our epaper please Read Now. For all the latest News, Mumbai, Entertainment, Cricket, Business and Featured News updates, visit Free Press Journal. Also, follow us on Twitter and Instagram and do like our Facebook page for continuous updates on the go)